Project Grant HT94252310617
Award Date
7/1/23
Completion Date
6/30/26
Dollars Obligated
$725K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
The University of Pittsburgh - Of The Commonwealth System of Higher Education, doing business as The University of Pittsburgh, was awarded a $636,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on a novel combination therapy targeting growth factor receptor cross talk with epitranscriptomic regulation in glioblastoma, a type of brain cancer, with the goal of developing innovative medical...
The University of Pittsburgh has been awarded a $747,131 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 10, 2024, supports the development of an Extracorporeal Perfusion System (EPS) for composite tissue regeneration. This research effort aims to advance innovative medical technologies to improve health outcomes for military service members and the broader public. The grant will fund a...
The University of Pittsburgh was awarded a $2,806,431.00 Project Grant on July 1, 2023 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to optimize small molecule therapeutics to treat focal segmental glomerulosclerosis. This basic, applied, and advanced biomedical research aims to transform health care by developing innovative and impactful medical solutions for Service Members and the American public. The University of Pittsburgh will...
The University of Pittsburgh - Of the Commonwealth System of Higher Education (University of Pittsburgh) was awarded a $1,246,455 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research to characterize a novel class of non-competitive androgen receptor antagonists from May 15, 2023 to May 14, 2026. The Military Medical Research and Development program aims to transform military and public health...
The University of Pittsburgh was awarded a $1,541,823 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant is for the project "FAST TILS TO TREAT METASTATIC CANCER PATIENTS WITH PLEURAL DISEASE" and runs from November 1, 2024 to October 31, 2028. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public, with a...
The University of Pittsburgh was awarded a $313,304 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) on July 1, 2024. The purpose of this 2-year grant is to conduct research on "Endothelial-Targeted Metallothionein Gene Editing to Enable VEGF Therapy in Rescuing Diabetic Pressure Ulcers." The project aims to develop new treatments for diabetic pressure ulcers by investigating gene editing techniques to enhance the...
The University of Pittsburgh has been awarded a $540,800 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on microparticle delivery of chemokine muteins guiding chemokine receptor engineered Treg for tolerance induction after vascular composite allograft transplant. The 3-year award, which runs from September 15, 2024 to September 14, 2027, will support innovative scientific studies aimed at developing novel...
The University of Pittsburgh received a $454,142.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "FERROPTOSIS AS A METABOLIC VULNERABILITY OF CYCLIN E-HIGH OVARIAN CANCER". This 2-year research project, with a performance period from May 2024 to May 2026, aims to investigate metabolic vulnerabilities in a specific type of ovarian cancer. The University of Pittsburgh is the primary...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $1,572,933.00 to the University of Pittsburgh to support research aimed at "TARGETING LYSOSOMAL PATHWAYS TO IMPROVE HOST IMMUNITY POST CORONAVIRAL INFECTIONS." The award commenced on January 1, 2025 and is scheduled for completion by December 31, 2028. As a major public research university, the University of Pittsburgh has extensive...
This $1,264,474 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the University of Pittsburgh's research on "Molecular Insights into Immune Suppression in Kidney Cancer and Novel Therapeutic Opportunities". The grant, effective September 1, 2024 through August 31, 2028, will fund the university's investigations into improving understanding of immune system mechanisms involved in kidney cancer and...